Moreover, subgroup analysis revealed that the correlations of cAMP-treated J774 with ApoA-I and preβ1-HDL in NAFLD patients were stronger than controls, and that ApoA-I and HDL-C were independents predictors for cAMP-treated J774 CEC in NAFLD patients. Here, APOA1 is linked to metabolic dysfunction-associated steatotic liver disease.